ABUS vs CCI
Arbutus Biopharma Corp (ABUS) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the ABUS and CCI stock pages for the full models.
Not investment advice.